Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (231-240 of 320) with videos related to

Pageof 32
Sort By:
Journal of Virology|December 28, 2012
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5Zahra F Parker, Shilpa S Iyer, Craig B Wilen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAlexandra Trkola, Shawn E Kuhmann, Julie M Strizki, et al.
Science (New York, N.Y.)|July 26, 2008
Whither or wither microbicides?Robert M Grant, Dean Hamer, Thomas Hope, et al.
Journal of Virology|April 7, 2017
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence ChangesRajesh P Ringe, Gabriel Ozorowski, Anila Yasmeen, et al.
Journal of Virology|February 17, 2017
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env TrimersEden P Go, Haitao Ding, Shijian Zhang, et al.
Virology|March 23, 2010
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry functionDirk Eggink, Mark Melchers, Manfred Wuhrer, et al.
Journal of Proteome Research|February 9, 2018
Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell LineagesAnna-Janina Behrens, Abhinav Kumar, Max Medina-Ramirez, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesR Karl Malcolm, Ronald S Veazey, Leslie Geer, et al.
Vaccine|July 2, 2009
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1Yun Kenneth Kang, Sofija Andjelic, James M Binley, et al.
Cell Reports|August 23, 2018
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric ImmunogenWeston B Struwe, Elena Chertova, Joel D Allen, et al.
Pageof 32

Showing results (231-240 of 320) with videos related to

Sort By:
Pageof 32
Journal of Virology|December 28, 2012
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5Zahra F Parker, Shilpa S Iyer, Craig B Wilen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2002
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 useAlexandra Trkola, Shawn E Kuhmann, Julie M Strizki, et al.
Science (New York, N.Y.)|July 26, 2008
Whither or wither microbicides?Robert M Grant, Dean Hamer, Thomas Hope, et al.
Journal of Virology|April 7, 2017
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence ChangesRajesh P Ringe, Gabriel Ozorowski, Anila Yasmeen, et al.
Journal of Virology|February 17, 2017
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env TrimersEden P Go, Haitao Ding, Shijian Zhang, et al.
Virology|March 23, 2010
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry functionDirk Eggink, Mark Melchers, Manfred Wuhrer, et al.
Journal of Proteome Research|February 9, 2018
Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell LineagesAnna-Janina Behrens, Abhinav Kumar, Max Medina-Ramirez, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaquesR Karl Malcolm, Ronald S Veazey, Leslie Geer, et al.
Vaccine|July 2, 2009
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1Yun Kenneth Kang, Sofija Andjelic, James M Binley, et al.
Cell Reports|August 23, 2018
Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric ImmunogenWeston B Struwe, Elena Chertova, Joel D Allen, et al.
Pageof 32